A detailed history of Aqr Capital Management LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 30,527 shares of BIO stock, worth $10.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
30,527
Previous 47,954 36.34%
Holding current value
$10.1 Million
Previous $13.1 Million 22.01%
% of portfolio
0.01%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$263.97 - $344.64 $4.6 Million - $6.01 Million
-17,427 Reduced 36.34%
30,527 $10.2 Million
Q2 2024

Aug 14, 2024

BUY
$268.26 - $339.48 $500,036 - $632,790
1,864 Added 4.04%
47,954 $13.1 Million
Q1 2024

May 15, 2024

BUY
$304.11 - $351.99 $2.93 Million - $3.39 Million
9,634 Added 26.43%
46,090 $15.9 Million
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $2.28 Million - $3.09 Million
8,459 Added 30.21%
36,456 $11.8 Million
Q3 2023

Nov 14, 2023

BUY
$350.25 - $422.63 $7.58 Million - $9.15 Million
21,651 Added 341.18%
27,997 $10 Million
Q2 2023

Aug 14, 2023

SELL
$359.49 - $486.4 $5.08 Million - $6.87 Million
-14,133 Reduced 69.01%
6,346 $2.41 Million
Q1 2023

May 15, 2023

SELL
$418.69 - $503.0 $5.66 Million - $6.8 Million
-13,514 Reduced 39.76%
20,479 $9.81 Million
Q4 2022

Feb 14, 2023

SELL
$351.71 - $456.01 $2.04 Million - $2.64 Million
-5,800 Reduced 14.58%
33,993 $14.3 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $12.2 Million - $16.7 Million
-29,690 Reduced 42.73%
39,793 $16.6 Million
Q2 2022

Aug 15, 2022

SELL
$463.67 - $597.16 $103 Million - $132 Million
-221,115 Reduced 76.09%
69,483 $34.1 Million
Q1 2022

May 16, 2022

BUY
$524.57 - $735.42 $32.4 Million - $45.4 Million
61,695 Added 26.95%
290,598 $164 Million
Q4 2021

Feb 14, 2022

BUY
$708.84 - $794.68 $35.7 Million - $40.1 Million
50,425 Added 28.25%
228,903 $172 Million
Q3 2021

Nov 15, 2021

BUY
$657.71 - $825.77 $7.73 Million - $9.71 Million
11,753 Added 7.05%
178,478 $133 Million
Q2 2021

Aug 16, 2021

BUY
$576.64 - $649.04 $7.67 Million - $8.64 Million
13,306 Added 8.67%
166,725 $107 Million
Q1 2021

May 17, 2021

BUY
$547.01 - $662.35 $1.39 Million - $1.68 Million
2,536 Added 1.68%
153,419 $87.5 Million
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $43.1 Million - $54.4 Million
-84,474 Reduced 35.89%
150,883 $86.3 Million
Q3 2020

Nov 16, 2020

SELL
$454.43 - $535.6 $53.8 Million - $63.4 Million
-118,431 Reduced 33.48%
235,357 $121 Million
Q2 2020

Aug 17, 2020

SELL
$334.87 - $493.06 $10.8 Million - $15.9 Million
-32,314 Reduced 8.37%
353,788 $155 Million
Q1 2020

May 15, 2020

BUY
$320.01 - $409.07 $21.2 Million - $27.1 Million
66,260 Added 20.72%
386,102 $135 Million
Q4 2019

Feb 14, 2020

BUY
$319.73 - $374.2 $43.9 Million - $51.4 Million
137,361 Added 75.27%
319,842 $118 Million
Q3 2019

Nov 14, 2019

BUY
$304.55 - $345.24 $6.94 Million - $7.86 Million
22,775 Added 14.26%
182,481 $60.7 Million
Q2 2019

Aug 14, 2019

SELL
$286.93 - $312.59 $25.1 Million - $27.3 Million
-87,486 Reduced 35.39%
159,706 $48.9 Million
Q1 2019

May 14, 2019

BUY
$224.3 - $317.41 $17.1 Million - $24.1 Million
76,072 Added 44.46%
247,192 $75.6 Million
Q4 2018

Feb 14, 2019

BUY
$220.1 - $309.0 $2.67 Million - $3.74 Million
12,112 Added 7.62%
171,120 $39.7 Million
Q3 2018

Nov 15, 2018

BUY
$289.28 - $326.15 $28.5 Million - $32.2 Million
98,634 Added 163.37%
159,008 $49.8 Million
Q2 2018

Aug 14, 2018

BUY
$244.1 - $303.88 $6.27 Million - $7.81 Million
25,702 Added 74.13%
60,374 $17.4 Million
Q1 2018

May 15, 2018

SELL
$233.97 - $274.11 $3.27 Million - $3.83 Million
-13,978 Reduced 28.73%
34,672 $8.67 Million
Q4 2017

Feb 14, 2018

BUY
$216.94 - $271.3 $3.89 Million - $4.86 Million
17,924 Added 58.33%
48,650 $11.6 Million
Q3 2017

Nov 14, 2017

BUY
$212.27 - $242.28 $6.52 Million - $7.44 Million
30,726
30,726 $6.83 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.15B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.